Of the two patients in the p16-positive group with disease recurrence, one patient had distant metastatic disease 23 months after primary treatment and one patient suffered from local recurrence 22 months after primary surgery and adjuvant radiation. Here, CDKN2A is linked to metastatic neoplasm.